03.01.2024 - Topline data from LIFT-AD on track for second half of 2024 Previously reported independent, unblinded interim analysis supports trial continuation and potential clinically meaningful activity of fosgonimeton Potential first-in-class approach . Seite 1
15.11.2023 - Data presented at Society for Neuroscience Annual Meeting 2023BOTHELL, Wash., Nov. 15, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore . Seite 1